NASDAQ

Aardvark Therapeutics, Inc. (AARD)

♥ 630 Thanks from members

Live price chart, market sentiment, and community perspectives for Aardvark Therapeutics, Inc. (NASDAQ: AARD).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: David RenLeadership: David Ren (CEO)Holder: Life Sciences Venture FundsHolder: Private Equity BackersAR-101Pipeline Therapeutics#AARD#Aardvark Therapeutics#Biotech#Clinical Stage#NASDAQ